Stocks and Investing
Stocks and Investing
Thu, March 30, 2017
[ 09:46 AM ] - United States, WOPRAI
[ 09:46 AM ] - United States, WOPRAI
[ 09:46 AM ] - United States, WOPRAI
[ 09:46 AM ] - United States, WOPRAI
[ 09:46 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Martin Auster Initiated (UTHR) at Strong Sell and Held Target at $112 on, Mar 30th, 2017
Martin Auster of UBS, Initiated "United Therapeutics Corporation" (UTHR) at Strong Sell and Held Target at $112 on, Mar 30th, 2017.
Martin has made no other calls on UTHR in the last 4 months.
There are 3 other peers that have a rating on UTHR. Out of the 3 peers that are also analyzing UTHR, 0 agree with Martin's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Martin
- Alethia Young of "Credit Suisse" Initiated at Sell on, Thursday, March 16th, 2017
- Eun Yang of "Jefferies" Downgraded from Hold to Sell and Held Target at $116 on, Monday, March 6th, 2017
- Hartaj Singh of "Oppenheimer" Initiated at Buy on, Wednesday, December 14th, 2016
Contributing Sources